183 related articles for article (PubMed ID: 1812354)
1. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
Schubeus P; Schörner W; Haustein J
Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
[No Abstract] [Full Text] [Related]
2. Gd-DTPA: an i.v. contrast agent for clinical MRI.
Runge VM
Int J Rad Appl Instrum B; 1988; 15(1):37-44. PubMed ID: 3280522
[No Abstract] [Full Text] [Related]
3. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis].
Tatsuno S; Hata Y; Tada S
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):855-9. PubMed ID: 8940816
[TBL] [Abstract][Full Text] [Related]
4. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.
Niendorf HP; Laniado M; Semmler W; Schörner W; Felix R
AJNR Am J Neuroradiol; 1987; 8(5):803-15. PubMed ID: 2823588
[TBL] [Abstract][Full Text] [Related]
5. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging of intracranial tumors using gadolinium-DTPA. Initial experience with fast imaging.
Niendorf HP; Felix R; Laniado M; Schörner W; Kornmesser W; Claussen C
Acta Radiol Suppl; 1986; 369():561-3. PubMed ID: 2980558
[TBL] [Abstract][Full Text] [Related]
7. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
Niemi P; Kurki T; Lundbom N; Kormano M
Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
[No Abstract] [Full Text] [Related]
8. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
[No Abstract] [Full Text] [Related]
9. Spin echo and inversion recovery sequences for gadolinium-DTPA enhanced magnetic resonance imaging of intracranial tumors.
Laniado M; Niendorf HP; Schörner W; Felix R
Acta Radiol Suppl; 1986; 369():469-71. PubMed ID: 2980530
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of MRI with Gd-DTPA in brain tumors].
Sakamoto Y; Takahashi M; Miyawaki M; Bussaka H; Wakamatsu H
Rinsho Hoshasen; 1988 Apr; 33(4):435-8. PubMed ID: 3398269
[No Abstract] [Full Text] [Related]
11. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
Hesselink JR; Healy ME; Press GA; Brahme FJ
J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
[TBL] [Abstract][Full Text] [Related]
12. Indications for the use of Gd-DTPA in MRI of the central nervous system. Experiences in patients with cerebral and spinal diseases.
Bauer WM; Fenzl G; Vogl T; Fink U; Lissner J
Invest Radiol; 1988 Sep; 23 Suppl 1():S286-8. PubMed ID: 3198363
[TBL] [Abstract][Full Text] [Related]
13. [Optimization of gadolinium-DTPA dose: an inter-individual study of patients with intracranial tumors].
Schubeus P; Schörner W; Haustein J; Hosten N; Niendorf HP; Felix R
Rofo; 1990 Jul; 153(1):29-35. PubMed ID: 2166308
[TBL] [Abstract][Full Text] [Related]
14. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with routine Gd-DTPA administration for MR imaging of the brain.
Schwaighofer BW; Klein MV; Wesbey G; Hesselink JR
J Comput Assist Tomogr; 1990; 14(1):11-7. PubMed ID: 2298973
[TBL] [Abstract][Full Text] [Related]
16. Use of MR imaging contrast agents in the brain.
Bradley WG; Yuh WT; Bydder GM
J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
[No Abstract] [Full Text] [Related]
17. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia.
Davis WK; Boyko OB; Hoffman JM; Hanson MW; Schold SC; Burger PC; Friedman AH; Coleman RE
AJNR Am J Neuroradiol; 1993; 14(3):515-23. PubMed ID: 8517334
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-DTPA in magnetic resonance imaging of the brain.
Valk J; De Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI
Neurosurg Rev; 1987; 10(2):87-92. PubMed ID: 3448513
[TBL] [Abstract][Full Text] [Related]
19. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
20. Gd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size.
Van Dijk P; Sijens PE; Schmitz PI; Oudkerk M
Magn Reson Imaging; 1997; 15(5):535-41. PubMed ID: 9253997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
